Get started
Author

Brad Wubbenhorst

Observed name: Bradly Wubbenhorst
OpenAlex ID: A5028482452
Abstract 5111: Integrative phospho-proteomic and genomic analyses identify AXL as a potential biomarker and therapeutic target for NRAS-mutated melanoma
2011 · Inna V. Fedorenko, Kim H.T. Paraiso, et al. · Cancer Research · 9
HRDex: a tool for deriving homologous recombination deficiency (HRD) scores from whole exome sequencing data
2022 · John Pluta, Ryan Hausler, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib
2026 · Kim A. Reiss, Mingyi Xia, et al. · JAMA Oncology · 1
Abstract 1682: Non-V600 BRAF mutants in melanoma: Multiple MAPK mutations and distinctive RNA expression
2019 · Elizabeth Kiernan, Paul Bastian, et al. · Molecular and Cellular Biology / Genetics
Abstract 1682: Non-V600 BRAF mutants in melanoma: Multiple MAPK mutations and distinctive RNA expression
2019 · Elizabeth Kiernan, Paul Bastian, et al. · Cancer Research
Abstract 4265: Risks of familial breast cancer associated with known and proposed breast cancer susceptibility genes
2017 · Kara N. Maxwell, Thomas Paul Slavin, et al. · Cancer Research
Works count: 6
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type